Correlation Between Quantum Genomics and Crossject

Can any of the company-specific risk be diversified away by investing in both Quantum Genomics and Crossject at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Quantum Genomics and Crossject into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Quantum Genomics SA and Crossject, you can compare the effects of market volatilities on Quantum Genomics and Crossject and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Quantum Genomics with a short position of Crossject. Check out your portfolio center. Please also check ongoing floating volatility patterns of Quantum Genomics and Crossject.

Diversification Opportunities for Quantum Genomics and Crossject

-0.03

Correlation Coefficient

Quantum Genomics  Crossject

Good diversification

The 3 months correlation between Quantum and Crossject is -0.03. Overlapping area represents the amount of risk that can be diversified away by holding Quantum Genomics SA and Crossject in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Crossject and Quantum Genomics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Quantum Genomics SA are associated (or correlated) with Crossject. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Crossject has no effect on the direction of Quantum Genomics i.e., Quantum Genomics and Crossject go up and down completely randomly.

Pair Corralation between Quantum Genomics and Crossject

Assuming the 90 days trading horizon Quantum Genomics SA is expected to generate 7.67 times more return on investment than Crossject. However, Quantum Genomics is 7.67 times more volatile than Crossject. It trades about 0.12 of its potential returns per unit of risk. Crossject is currently generating about -0.04 per unit of risk. If you would invest  2.62  in Quantum Genomics SA on September 26, 2024 and sell it today you would earn a total of  4.59  from holding Quantum Genomics SA or generate 175.19% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Quantum Genomics SA  vs.  Crossject

Quantum Genomics

Risk-Adjusted Performance

9 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Quantum Genomics SA are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. Even with relatively weak basic indicators, Quantum Genomics reported solid returns over the last few months and may actually be approaching a breakup point.

Crossject

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Crossject has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

Pair Trading with Quantum Genomics and Crossject

The main advantage of trading using opposite Quantum Genomics and Crossject positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Quantum Genomics position performs unexpectedly, Crossject can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Crossject will offset losses from the drop in Crossject's long position.

The idea behind Quantum Genomics SA and Crossject pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..